Newsletter Signup | Community
Dr. Jaglowski is a lymphoma expert and the medical director of Ohio State’s Stem Cell Transplant Program.
Answers to frequently asked questions about bone marrow aspiration and biopsy evaluation in lymphoma.
Checkmate 436 clinical trial reported at ASH suggests the targeted immunotherapy combination is very promising.
The Selective Inhibitor of Nuclear Export (SINE) Selinexor being developed as new treatment for lymphoma.
Novel Bispecific monoclonal antibody treatment appears promising for non-hodgkin lymphoma
Research demonstrates that some patients with NHL can be treated with 4 instead of 6 cycles of R-CHOP.
Curious is others with celiac disease have develeoped lymphoma?
Long-Term Follow-Up Indicates Continued Improvement in Survival with Addition of Rituxan® to CHOP in NHL
